CLEARING THE AIR AROUND THE USE OF IVERMECTIN FOR COVID-19 PATIENTS
May 19, 2021
When the pandemic first broke out, repurposing broad-spectrum antiviral agents were deemed ‘safe’ through testing on early phase clinical trials for Covid-19. Thereafter, many drugs were put to use availing the emergency authorisation with government agencies. One such drug was Ivermectin which is mainly prescribed for patients with mild to...
Read More